Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID‐19 in the Omicron variant era: A national cohort study in Iran
Journal of Medical Virology · 2023-03 · 95 (3)
DOI: 10.1002/jmv.28607 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Medical Virology, 2023-03. Verfasst von Hamidreza Jamaati und 20 weiteren Autor:innen. Beteiligte Einrichtung: Chronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Scie…. Hauptthemen laut MEDLINE: COVID-19, Vaccines. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Various severe acute respiratory syndrome coronavirus 2 vaccines with different platforms have been administered worldwide; however, their effectiveness in critical cases of COVID‐19 has remained a concern. In this national cohort study, 24 016 intensive care unit (ICU) coronavirus disease‐2019 (COVID‐19) admissions were included from January to April 2022. The mortality and length of ICU stay were compared between the vaccinated and unvaccinated patients. A total of 9428 (39.25%) patients were unvaccinated, and 14 588 (60.75%) patients had received at least one dose of the vaccine. Compared with the unvaccinated, the first, second, and third doses of vaccine resulted in 8%, 20%, and 33% lower risk of ICU mortality in the adjusted model, with risk ratio (RR): 0.92, 95% confidence interval (CI): 0.84–1.001, RR: 0.80, 95% CI: 0.77–0.83, and RR: 0.67, 95% CI: 0.64–0.71, respectively. The mean survival time was significantly shorter in the unvaccinated versus the fully vaccinated patients (hazard ratio [HR]: 0.84, 95% CI: 0.80–0.88); p < 0.001). All vaccine platforms successfully decreased the hazard of ICU death compared with the unvaccinated group. The duration of ICU stay was significantly shorter in the fully vaccinated than in unvaccinated group (MD, −0.62, 95% CI: −0.82 to −0.42; p < 0.001). Since COVID‐19 vaccination in all doses and platforms has been able to reduce the risk of mortality and length of ICU‐stay, universal vaccination is recommended based on vaccine availability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Science, Tehran, Iran.
- Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Pharmacotherapy Department, Faculty of Pharmacy, Bagyattallah University of Medical Sciences, Tehran, Iran.
- Department of Biostatistics, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
- Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Shadi Shafaghi
Zitieren
APA
Jamaati, H., Karimi, S., Ghorbani, F., Panahi, Y., Hosseini-Baharanchi, F. S., Hajimoradi, M., Malek, R., Noorali, S., Mokhtari, M., Khoundabi, B., Sadr, M., Mohamadnia, A., Zahraei, S. M., Hashemian, S. M., Dastan, F., Mortaz, E., Tayeri, K., Behtaj, F., Vaezi, H., …, & Shafaghi, S. (2023). Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID‐19 in the Omicron variant era: A national cohort study in Iran. Journal of Medical Virology, 95(3). https://doi.org/10.1002/jmv.28607
Vancouver
Jamaati H, Karimi S, Ghorbani F, Panahi Y, Hosseini-Baharanchi FS, Hajimoradi M, et al. Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID‐19 in the Omicron variant era: A national cohort study in Iran. Journal of Medical Virology. 2023;95(3). doi:10.1002/jmv.28607
BibTeX
@article{Jamaati2023,
author = {Jamaati, Hamidreza and Karimi, Saeed and Ghorbani, Fariba and Panahi, Yunes and Hosseini-Baharanchi, Fatemeh Sadat and Hajimoradi, Maryam and Malek, Rayka and Noorali, Sima and Mokhtari, Majid and Khoundabi, Batoul and Sadr, Makan and Mohamadnia, Abdolreza and Zahraei, Seyed Mohsen and Hashemian, Seyed MohammadReza and Dastan, Farzaneh and Mortaz, Esmaeil and Tayeri, Katayoun and Behtaj, Fatemeh and Vaezi, Hassan and Forouzanfar, Mohammad Mehdi and Shafaghi, Shadi},
title = {Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID‐19 in the Omicron variant era: A national cohort study in Iran},
journal = {Journal of Medical Virology},
year = {2023},
volume = {95},
number = {3},
doi = {10.1002/jmv.28607}
}
EUVIMED